Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Perspective Therapeutics (CATX) Net Income towards Common Stockholders (2016 - 2025)

Perspective Therapeutics (CATX) has disclosed Net Income towards Common Stockholders for 16 consecutive years, with $514000.0 as the latest value for Q2 2025.

  • Quarterly Net Income towards Common Stockholders rose 204.9% to $514000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $514000.0 through Dec 2025, up 154.16% year-over-year, with the annual reading at $514000.0 for FY2025, 154.16% up from the prior year.
  • Net Income towards Common Stockholders hit $514000.0 in Q2 2025 for Perspective Therapeutics, up from -$490000.0 in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $514000.0 in Q2 2025 to a low of -$5.2 million in Q4 2023.
  • Historically, Net Income towards Common Stockholders has averaged -$1.7 million across 5 years, with a median of -$1.5 million in 2023.
  • Biggest five-year swings in Net Income towards Common Stockholders: tumbled 213.27% in 2021 and later skyrocketed 204.9% in 2025.
  • Year by year, Net Income towards Common Stockholders stood at -$1.6 million in 2021, then crashed by 41.83% to -$2.3 million in 2022, then tumbled by 127.82% to -$5.2 million in 2023, then soared by 90.55% to -$490000.0 in 2024, then surged by 204.9% to $514000.0 in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for CATX at $514000.0 in Q2 2025, -$490000.0 in Q2 2024, and -$459000.0 in Q1 2024.